Clinical Trial Update: VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for VG101 in Phase I/II for vulvar and vaginal atrophy in post-menopausal women; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy
• Vulvar Atrophy

Drugs mentioned

• VG101

Snippet

Sponsor: Bionovo | Conditions: Vaginal Atrophy, Vulvar Atrophy | Phase 1, Phase 2 | Status: UNKNOWN